Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Almirall

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Almirall's 2013 sales performance.

Almirall expands in US via $400m deal to buy Aqua

Almirall expands in US via $400m deal to buy Aqua In a statement Almirall noted that "dermatology is a key platform of growth and continues to be a key future growth driver". ... The transaction is expected to be immediately accretive to earnings, said Almirall, which will fund the deal with debt.

Forest Labs slashes staff and bolsters product portfolio

Forest Labs slashes staff and bolsters product portfolio Richter, as well as delays to filing of a chronic obstructive pulmonary disorder (COPD) combination treatment based on aclidinium bromide and formoterol fumarate and partnered with Almirall.

Interview: Allan Hillgrove, Boehringer

Interview: Allan Hillgrove, Boehringer Boehringer isn't alone in its view either, and Bayer, Cell Therapeutics, Almirall, GlaxoSmithKline and Eisai have all seen drugs fail to impress the country's authorities.

Novartis' combo COPD inhaler cleared in EU

Novartis' combo COPD inhaler cleared in EU Novartis has not yet filed for approval of Ultibro in the US), whileand Forest Labs/Almirall are all bringing their own LAMA/LABA combinations through the pipeline.

FDA queries safety of GSK's Anoro for COPD

FDA queries safety of GSK's Anoro for COPD bromide/indacaterol maleate) and Forest Labs/Almirall's aclidinium bromide/formoterol candidate.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics